TET2 and neoplasm: TET2 is often silenced or mutated in myelo proliferative disease (MPD), myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia (CMML) and lymphomas suggesting a tumor suppressor role for TET2 in myeloid tumors, MPD and MDS.